If your migraines repeatedly arrive with your period, have you ever tracked them closely enough to show your doctor the pattern?
If your worst migraines seem to arrive on schedule with your period, you are probably not imagining the pattern.
Hormonal fluctuations around menstruation can trigger migraine attacks that may be longer, more severe and harder to treat than attacks at other times of the month. Now a late-stage clinical trial has tested an intriguing strategy: instead of taking a preventive drug every day, women took it for only seven days surrounding their periods.
The results were positive, raising the possibility of a new treatment approach designed specifically around a predictable hormonal trigger.
Menstrual migraine is a real clinical pattern
Migraine is far more common in women than men, and hormonal changes are one reason.
Estrogen levels fall sharply just before menstruation. For some women, that drop appears to lower the threshold for a migraine attack.
A menstrual migraine typically occurs in a window around the start of a period. Some women have migraines almost exclusively during that window, while others experience attacks throughout the month that become especially likely or severe around menstruation.
Recognizing the timing can be the first step toward treating the pattern more strategically.
The new trial used a drug already approved for migraine prevention
The drug is atogepant, sold in the United States under the brand name Qulipta. It belongs to a newer class of migraine medications that target calcitonin gene-related peptide, or CGRP, a pathway involved in migraine.
Atogepant is already FDA-approved as a preventive treatment for migraine in adults. What is new is the way researchers used it.
In the Phase 3 LUNA trial, women took atogepant for seven consecutive days beginning three days before the expected start of menstruation, over three menstrual cycles.
The treatment reduced migraine days
According to results announced September 10, women receiving atogepant experienced a greater reduction in perimenstrual migraine days than women receiving placebo.
The difference between groups averaged 0.8 fewer migraine days across the menstrual window. The trial also reported improvements in headache burden, use of acute migraine medication, functional disability and cognitive functioning.
Reuters reported the late-stage trial results.
That 0.8-day difference may not sound enormous to someone who doesn’t have migraine. For someone who loses one or more days of normal life every month to severe pain, nausea and light sensitivity, it may be meaningful.
Why taking prevention only around the period is interesting
Preventive migraine medications are often taken continuously. That makes sense for people who have frequent or unpredictable attacks throughout the month.
But menstrual migraine has something many migraines don’t: a partially predictable trigger window.
If a preventive treatment can be concentrated around the days of greatest vulnerability, some women may be able to reduce attacks without taking that particular preventive medication every day.
That is the idea behind short-term or “mini-prevention” strategies, which clinicians already use with some migraine medications around menstruation.
This isn’t an approved menstrual-migraine regimen yet
The topline results are promising, but there is an important distinction.
Atogepant is approved for migraine prevention generally. The seven-day menstrual regimen studied in LUNA is not yet a separately FDA-approved treatment specifically for menstrual migraine.
Save this article
Enter your email address and we'll send it straight to your inbox.
The results were announced by the manufacturer and still need full scientific presentation and regulatory review.
Women should not simply begin changing the way they take a prescription migraine drug based on a news story.
How to know whether your migraines are menstrual
A headache diary can be surprisingly useful.
Track when each migraine begins, how long it lasts, the first day of each menstrual period, medications used and possible triggers. After a few cycles, a pattern may become obvious.
If attacks repeatedly cluster in the days immediately before and after menstruation, show the diary to your healthcare provider.
This can also help distinguish a true menstrual pattern from migraines triggered by sleep changes, dehydration, stress, skipped meals or other factors that happen to coincide with certain times of the month.
READ: When your period isn’t just your period: 7 changes worth mentioning to your doctor
Migraine with aura changes some conversations
Some women experience aura before or during migraine—neurological symptoms such as visual disturbances, tingling or speech changes.
Migraine with aura is relevant when discussing estrogen-containing contraception because it is associated with increased ischemic stroke risk, and combined hormonal contraceptives may not be appropriate for some women with aura.
That doesn’t mean all hormonal treatment is off the table. It means your clinician needs to know whether you experience aura before recommending a strategy involving hormones.
There are treatments available now
Women don’t have to wait for the LUNA regimen to reach clinical practice.
Acute migraine treatments include triptans, gepants and other medications. Preventive options include several drug classes as well as CGRP-targeting medications. Some clinicians also use short-term preventive strategies around menstruation in appropriate patients.
The right approach depends on attack frequency, severity, aura status, other medical conditions, pregnancy plans and how well previous treatments have worked.
Don’t normalize losing several days every month
Many women quietly organize their lives around menstrual migraine. They avoid scheduling important events, expect to lose a workday or spend a weekend in bed because “that’s just what my period does.”
Migraine is a neurological disease, not a test of endurance.
If your period reliably brings disabling headaches, nausea, vomiting, light sensitivity or neurological symptoms, tell a healthcare provider about the timing—not just the headaches. That pattern can affect treatment decisions.
Final word
The most interesting thing about the new trial may not be the drug itself. It is the idea that migraine treatment can be designed around a woman’s hormonal cycle rather than treating every day of the month as biologically identical.
The seven-day atogepant strategy still needs full review, and it will not be appropriate for everyone. But the results validate something women with menstrual migraine have known for years: the timing of their attacks isn’t random, and it deserves to be taken seriously.
QUESTION FOR READERS: If your migraines repeatedly arrive with your period, have you ever tracked them closely enough to show your doctor the pattern?
